PCMA: Governor Sherrill’s Budget Address Misses Mark on High Drug Costs

The Pharmaceutical Care Management Association (PCMA) issued the following statement on New Jersey Governor Mikie Sherrill’s budget address: “The governor’s remarks today about pharmacy benefit managers (PBMs) are simply untrue and misleading to New Jersey patients, and it is imperative to correct the record. The mission of PBMs is to reduce prescription drug costs, and […]

PCMA Supports Trump Administration’s Action to Increase Biosimilars Access

(Washington, D.C.) – The Trump Administration is taking action to increase access to biosimilars. Congress can take the administration’s lead and entirely eliminate the interchangeability designation for biosimilars. In response to the new draft guidance, issued yesterday by the Food and Drug Administration, Pharmaceutical Care Management Association President and CEO, David Marin, issued the following statement: “No other […]